At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BBH VanEck Biotech ETF
Trading 10-08 14:06:39 EDT
232.71
-5.17
-2.17%
High236.45Low230.26Vol13.84K
Open236.45D1 Closing237.87Amplitude2.60%
Mkt Cap466.92MTradable Cap466.92MTotal Shares2.01M
T/O3.20MT/O Rate0.69%Tradable Shares2.01M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial
TIPRANKS  ·  00:31
Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial
Revolution trading down after daraxonrasib review docs, says Stifel
TIPRANKS  ·  00:05
Revolution trading down after daraxonrasib review docs, says Stifel
Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson
Dow Jones  ·  10-08 22:51
Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson
Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)
TIPRANKS  ·  10-08 20:10
Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)
Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances
TradingKey  ·  10-08 20:00
Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances
Sino Biopharmaceutical Stock Slides 3.3% in Hong Kong
Dow Jones  ·  10-08 16:32
Sino Biopharmaceutical Stock Slides 3.3% in Hong Kong
Will Phase 3 Trial Start Change Revolution Medicines (RVMD) Narrative
Simply Wall St.  ·  10-08 15:26
Will Phase 3 Trial Start Change Revolution Medicines (RVMD) Narrative
Amgen Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  10-08 04:34
Amgen Inc. Stock Outperforms Competitors on Strong Trading Day
Moderna Inc. Stock Rises 4.8%, Outperforms Peers
Dow Jones  ·  10-08 04:33
Moderna Inc. Stock Rises 4.8%, Outperforms Peers
Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast
Reuters  ·  10-08 04:00
Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast
NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-07
Reuters  ·  10-08 02:45
NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-07
Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis
TradingKey  ·  10-08 00:15
Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis
Regeneron Pharma Price Target Raised to $779.00/Share from $758.00 by Morgan Stanley
Dow Jones  ·  10-07 23:05
Regeneron Pharma Price Target Raised to $779.00/Share from $758.00 by Morgan Stanley
Amgen is Maintained at Equal-Weight by Morgan Stanley
Dow Jones  ·  10-07 22:33
Amgen is Maintained at Equal-Weight by Morgan Stanley
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
TIPRANKS  ·  10-07 22:00
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
Early notable gainers among liquid option names on October 7th
TIPRANKS  ·  10-07 21:55
Early notable gainers among liquid option names on October 7th
Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib
GlobeNewswire  ·  10-07 20:30
Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib
J.P. Morgan Remains a Buy on Gilead Sciences (GILD)
TIPRANKS  ·  10-07 19:37
J.P. Morgan Remains a Buy on Gilead Sciences (GILD)
Gilead : JP Morgan Raises Target Price to $170 from $160
THOMSON REUTERS  ·  10-07 12:19
Gilead : JP Morgan Raises Target Price to $170 from $160
Moderna Inc. Stock Slips 7.8%, Underperforms Peers
Dow Jones  ·  10-07 04:32
Moderna Inc. Stock Slips 7.8%, Underperforms Peers

Introduction

Company Name.
VanEck Biotech ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Issue price:
--